КАРДИОЛОГИЯ УЗБЕКИСТАНА, Journal Year: 2024, Volume and Issue: 18(1), P. 138 - 140
Published: Dec. 4, 2024
Language: Английский
КАРДИОЛОГИЯ УЗБЕКИСТАНА, Journal Year: 2024, Volume and Issue: 18(1), P. 138 - 140
Published: Dec. 4, 2024
Language: Английский
Circulation Cardiovascular Interventions, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 22, 2025
Some patients with aortic stenosis may require multiple valve interventions in their lifetime, and choosing transcatheter replacement (TAVR) as the initial intervention be appealing to many. If heart degenerates later life, most will hope undergo redo-TAVR. However, if redo-TAVR is not feasible, some have surgical explantation of (TAVR-explant). With rising numbers TAVR younger patients, we address practical implications a TAVR-first strategy. In this review explore potential factors contributing higher-than-expected mortality after TAVR-explant, synthesize available outcomes data for TAVR-explant structurally degenerated valves, describe strategies standardize optimize techniques TAVR-explant. We also discuss clinical within context limitations currently published series highlight benefit virtual planning assess feasibility future before implanting first valve. Finally, areas investigation inform management who interventions.
Language: Английский
Citations
0American Heart Journal, Journal Year: 2025, Volume and Issue: unknown
Published: April 1, 2025
Language: Английский
Citations
0Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(8), P. 2770 - 2770
Published: April 17, 2025
With recent guidelines expanding transcatheter aortic valve replacement (TAVR) to younger patients, indications for redo-TAVR will also likely increase. When compared with TAVR, is a rare and novel procedure. Current clinical data derived from registries suggest excellent safety, low rates of 30-day 1-year mortality following redo-TAVR. Proper understanding bench studies regarding optimal configurations, patient anatomy the technical properties heart valves (THV) essential selection procedural success. Lifetime management should start before index procedure, as choice THV has major impact on feasibility Procedural optimization by adequate sizing, commissural alignment implant depth both redo-THV are critical determinants hemodynamics maximized longevity, well lifelong coronary access.
Language: Английский
Citations
0Current Opinion in Cardiology, Journal Year: 2025, Volume and Issue: unknown
Published: April 25, 2025
Predicting and preventing coronary obstruction in transcatheter aortic valve replacement (TAVR) is crucial due to its high mortality risk. In native TAVR, predicting requires assessing cusp height, artery valve-to-coronary distance, leaflet calcium volume. The VIVID classification has been proposed for evaluating the risk of TAVR failed bioprosthetic surgical valves. After with Sapien 3 valve, feasibility redo access decreases a shallower implantation initial 3. within an Evolut positioning outflow at node 4 improves accessibility compared nodes 5 or 6. For sizing 3, in-vivo CT results smaller sizes than bench sizing, reducing improving feasibility. Leaflet modification stenting techniques dedicated leaflet-splitting device have maintain perfusion high-risk cases. Coronary preservation remains significant challenge, requiring further research into preprocedural planning strategies.
Language: Английский
Citations
0The Lancet, Journal Year: 2025, Volume and Issue: unknown
Published: April 1, 2025
Language: Английский
Citations
0КАРДИОЛОГИЯ УЗБЕКИСТАНА, Journal Year: 2024, Volume and Issue: 17(21), P. 2455 - 2471
Published: Nov. 1, 2024
Language: Английский
Citations
1КАРДИОЛОГИЯ УЗБЕКИСТАНА, Journal Year: 2024, Volume and Issue: 17(22), P. 2575 - 2595
Published: Nov. 1, 2024
Language: Английский
Citations
1КАРДИОЛОГИЯ УЗБЕКИСТАНА, Journal Year: 2024, Volume and Issue: 18(1), P. 138 - 140
Published: Dec. 4, 2024
Language: Английский
Citations
0